Works matching IS 00185787 AND DT 2010 AND VI 45 AND IP 11
Results: 22
Review of Antibiogram Preparation and Susceptibility Testing Systems.
- Published in:
- Hospital Pharmacy, 2010, v. 45, n. 11, p. S6, doi. 10.1310/hpj4511-S6
- By:
- Publication type:
- Article
How to Make Antimicrobial Stewardship Work: Practical Considerations for Hospitals of All Sizes.
- Published in:
- Hospital Pharmacy, 2010, v. 45, n. 11, p. S10, doi. 10.1310/hpj4511-S10
- By:
- Publication type:
- Article
Importance and Impact of Antimicrobial Stewardship.
- Published in:
- Hospital Pharmacy, 2010, v. 45, n. 11, p. S1, doi. 10.1310/hpj4511-S1
- By:
- Publication type:
- Article
Current FDA-related drug information.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
ISMP adverse drug reactions.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Editorial. Association of trial outcome and funding source.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Cancer chemotherapy update.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Formulary drug reviews. Buprenorphine transdermal system.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
ISMP medication error report analysis.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
ISMP Medication Error Report Analysis - Electronic Prescribing Vulnerabilities: Height and Weight Mix-Up Leads to Dosing Error; Null Sign Misread; Look-Alike Vials.
- Published in:
- Hospital Pharmacy, 2010, v. 45, n. 11, p. 816, doi. 10.1310/hpj4511-816
- By:
- Publication type:
- Article
Editorial - Association of Trial Outcome and Funding Source.
- Published in:
- 2010
- By:
- Publication type:
- Editorial
ISMP Adverse Drug Reactions - Severe Rhabdomyolysis During Sunitinib Therapy; Meropenem-Induced Vanishing Bile Duct Syndrome; Infliximab-Induced Lichen Planopilaris; Papulopustular Eruption Associated With Panitumumab; Serotonin Syndrome With Sertraline and Indomethacin; Review: Heparin-Induced Thrombocytopenia; Review: Amiodarone and Thyroid Dysfunction
- Published in:
- Hospital Pharmacy, 2010, v. 45, n. 11, p. 822, doi. 10.1310/hpj4511-822
- By:
- Publication type:
- Article
Cancer Chemotherapy Update - Cabazitaxel; Ipilimumab.
- Published in:
- Hospital Pharmacy, 2010, v. 45, n. 11, p. 828, doi. 10.1310/hpj4511-828
- By:
- Publication type:
- Article
Formulary Drug Reviews - Buprenorphine Transdermal System.
- Published in:
- Hospital Pharmacy, 2010, v. 45, n. 11, p. 863, doi. 10.1310/hpj4511-863
- By:
- Publication type:
- Article
RxLegal - Academic Detailing and the IDEA Act.
- Published in:
- Hospital Pharmacy, 2010, v. 45, n. 11, p. 839, doi. 10.1310/hpj4511-839
- By:
- Publication type:
- Article
Strategies to Address Appropriate Fluoroquinolone Use in the Hospital.
- Published in:
- Hospital Pharmacy, 2010, v. 45, n. 11, p. 844, doi. 10.1310/hpj4511-844
- By:
- Publication type:
- Article
Pharmacy Automation and Technology - Pharmacy, Health Information Technology, and the Medical Home: Achieving the Whole Picture.
- Published in:
- Hospital Pharmacy, 2010, v. 45, n. 11, p. 880, doi. 10.1310/hpj4511-880
- By:
- Publication type:
- Article
Off-Label Drug Uses - Uremic Pruritus: Naltrexone.
- Published in:
- Hospital Pharmacy, 2010, v. 45, n. 11, p. 836, doi. 10.1310/hpj4511-836
- By:
- Publication type:
- Article
The Influence of Gluten on Patient Medication Choices.
- Published in:
- Hospital Pharmacy, 2010, v. 45, n. 11, p. 841, doi. 10.1310/hpj4511-841
- By:
- Publication type:
- Article
Documentation of Clinical Activities Using a Web-Based Application Within an Eight Hospital Integrated Health Care System: A Six-Year Experience.
- Published in:
- Hospital Pharmacy, 2010, v. 45, n. 11, p. 854, doi. 10.1310/hpj4511-854
- By:
- Publication type:
- Article
Hospital Pharmacy Pulse - Recent Publications on Medications and Pharmacy.
- Published in:
- Hospital Pharmacy, 2010, v. 45, n. 11, p. 882, doi. 10.1310/hpj4511-882
- By:
- Publication type:
- Article
Current FDA-Related Drug Information - New Drugs Approved by the FDA; New Dosage Forms and Indications Approved by the FDA; Agents Pending FDA Approval; Significant Labeling Changes or 'Dear Health Professional' Letters Related to Safety.
- Published in:
- Hospital Pharmacy, 2010, v. 45, n. 11, p. 874, doi. 10.1310/hpj4511-874
- By:
- Publication type:
- Article